We are dedicated to improving the lives of people impacted by diabetes through research, education, and clinical care. Sansum Diabetes Research Institute (SDRI) in Santa Barbara, California, is a global leader in diabetes research. SDRI has been on the cutting edge of diabetes research, education, and clinical care since our founding in 1944 by Dr. William Sansum, the first U.S. physician to manufacture and administer insulin in the treatment of diabetes.
With an established world class reputation for innovation in the field of type 1 diabetes including the artificial pancreas system and diabetes in pregnancy, SDRI is broadening its area of expertise to address a range of issues in type 2 diabetes in an effort to address this growing epidemic.
With an established world class reputation for innovation in the field of type 1 diabetes including the artificial pancreas system and diabetes in pregnancy, SDRI is broadening its area of expertise to address a range of issues in type 2 diabetes in an effort to address this growing epidemic.
Follow us
Services
SDRI was established in 1944 by world-renowned medical pioneer, Dr. William Sansum, who was the first United States physician to successfully manufacture and administer life-saving insulin in the treatment of diabetes. Dr. Sansum made history treating a terminally ill patient, Charles Cowan, with insulin, saving his life and countless others.
Sansum Diabetes Research Institute was established in 1944 by Dr. William Sansum, the first physician in the United States to manufacture and administer life-saving insulin to people with type 1 diabetes. Today, SDRI is an institution that is respected worldwide for its research that impacts the care of those with type 1 and type 2 diabetes as well as those with diabetes in pregnancy.
SDRI IS ON THE CUTTING EDGE of research into new technologies designed to improve the lives of people living with diabetes. We have participated in key pivotal trials of commercial automated insulin delivery devices, and served as a clinical site in the trials of Tandem Diabetes' Control-IQ and Basal-IQ technology, as well as for the hybrid closed loop system Omnipod 5.
Reviews
Be the first to review Sansum Diabetes Research Institute: Jovanovic Lois.
Write a Review
